BOK Financial Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2
Closed -$827 569
2024
Q4
$827 Buy
+2
New +$877 ﹤0.01% 526
2022
Q2
Sell
-380
Closed -$208K 407
2022
Q1
$208K Sell
380
-60
-14% -$31.6K 0.01% 295
2021
Q4
$290K Buy
440
+11
+3% +$6.91K 0.02% 231
2021
Q3
$267K Buy
429
+74
+21% +$49.7K 0.02% 209
2021
Q2
$224K Buy
+355
New +$196K 0.02% 209

Other funds holding IDXX

BOK Financial Private Wealth's IDXX Position: Q1 2025 in Review

BOK Financial Private Wealth sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 2 shares — an estimated $827 sold.

BOK Financial Private Wealth first reported a position in IDXX in Q2 2021 and held it in 5 quarters. The position peaked at $290K in Q4 2021. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • BOK Financial Private Wealth reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • BOK Financial Private Wealth sold 2 Idexx Laboratories shares in Q1 2025, an estimated $827.
  • BOK Financial Private Wealth first reported a position in Idexx Laboratories in Q2 2021 and held it in 5 quarters.
  • BOK Financial Private Wealth's Idexx Laboratories position peaked at $290K in Q4 2021.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on BOK Financial Private Wealth's 13F filing for Q1 2025, filed 14 May 2025.